I am facing a bit of a dilemma. I have had a lumpectomy and reconstruction and I have just had another op as i do not have clear margins. The pathology results show that I am triple positive and the 60mm area that was removed was mainly high grade DCIS with a grade 2, 8mm tumour and no lymph node involvement. All very positive. When I spoke to the oncologist the prognosis is very good because it was caught early, however, I was a bit taken aback when she offered treatment for the HER2 positive which is 12 weekly taxol and 6months of Herceptin. I appreciate that my results have taken into consideration as it is a less aggressive chemo and 6mths as opposed to 12 months of Herceptin but the oncologist stated it is my choice. Has anyone else been in this position with a small invasive tumour? I cannot find much information on recurrence rates for HER2 positive tumours? I know all about the Predict Tool but I am really looking for information on recurrence not survival rates. Sorry to ramble on, I know I am lucky, but I am really unsure about what to do.
Morning Mrsmagoo , I am ER and HER2 positive . I have just started my chemo - I had a19mm invasive ductal cancer, with high grade DCIS, 39mm, successful clearance and no node involvement.
I am 57, and having 3 x Epirubicin with 3x cyclophosphamide
followed by 3 Docetaxel with Trastuzumab (Herceptin), I have been advised the Herceptin for 6/12 and this is the response from my oncologist- as I had originally been told 12/12 and then changed to 6/12. I hope this is useful, but keep asking until you are ok with your treatment plan. Hopefully less cardio toxicity from 6/12 rather than 12/12. My understanding is that the HER2 protein makes it a more aggressive form and I was grade 3 , so aggressive end of the spectrum, so I accepted chemotherapy/ Herceptin into my plan.
Followed by radiotherapy and the oestrogen lowering medication and bisphosphanates to follow.
This is based on data from a large clinical trial called Persephone which demonstrated no benefit from 12m herceptin v 6m herceptin in patients with cancers <3cm which were node negative
NICE has not updated it guidelines to reflect this trial yet but it is UK practice and certainly the practice at the Christie.
Xx
Hi Mrsmagoo, I too was diagnosed with triple positive breast cancer but I had lymph node involvement. I have just finished 8 rounds of chemo and am now on radiotherapy. I am having a year of Phesgo injections every 3 weeks plus hormone treatment for 5 years.
Reoccurrence is a worrying thing but we are all so different it is possibly hard to say. I’m just taking what I is offered as I don’t have any medical background and I trust in my medical team that they are doing everything possible to help prevent reoccurrence.
I’ve read a few articles and found these sites which might be of interest
www.breastcancer.org/.../20091104
Wishing you all the best with your journey
Hugs from cuffcake x x x x x
Hi Mrsmagoo my story on profile if you want to read .
Ive finished treatment ..I had 12month Herceptin but know that new research suggests 6 month can be enough ( all depending on your plan etc )
I asked what did Herceptin do ? The answer from Onco was with HER2 there was 50% risk of recurrence within 3yr this was reduced to 20% after Herceptin .
I’m now 4yr after diagnosis and there are others whom are ahead of me .
good luck with rest of treatment
Whatever cancer throws your way, we’re right there with you.
We’re here to provide physical, financial and emotional support.
© Macmillan Cancer Support 2025 © Macmillan Cancer Support, registered charity in England and Wales (261017), Scotland (SC039907) and the Isle of Man (604). Also operating in Northern Ireland. A company limited by guarantee, registered in England and Wales company number 2400969. Isle of Man company number 4694F. Registered office: 3rd Floor, Bronze Building, The Forge, 105 Sumner Street, London, SE1 9HZ. VAT no: 668265007